The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Redmond, Michele Emily, Dr
    Academic born in July 1976
    Individual (1 offspring)
    Officer
    2015-09-18 ~ now
    OF - director → CIF 0
  • 2
    Darby, Rosalind May
    Research Commercialisation Manager born in July 1967
    Individual (1 offspring)
    Officer
    2016-06-01 ~ now
    OF - director → CIF 0
  • 3
    MERCIA FUND MANAGEMENT (NOMINEES) LIMITED
    Forward House, High Street, Henley-in-arden, England
    Corporate (6 parents, 63 offsprings)
    Officer
    2021-02-01 ~ now
    OF - director → CIF 0
  • 4
    Ordinance House, 31 Pier Road, St Helier, Jersey, Jeresy
    Corporate (1 offspring)
    Person with significant control
    2018-01-23 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% with control over the trustees of a trust → CIF 0
Ceased 9
  • 1
    Gibson, Stuart James
    Finance Director born in March 1967
    Individual (4 offsprings)
    Officer
    2015-12-08 ~ 2020-04-10
    OF - director → CIF 0
  • 2
    Sundstrom, Susan Margaret
    Manager born in May 1957
    Individual (2 offsprings)
    Officer
    2015-04-23 ~ 2016-06-01
    OF - director → CIF 0
  • 3
    Alexandroff, James Michael
    Investor born in February 1958
    Individual (15 offsprings)
    Officer
    2016-04-04 ~ 2016-08-07
    OF - director → CIF 0
  • 4
    Brooksby, Nigel
    Chairman born in August 1950
    Individual (12 offsprings)
    Officer
    2017-09-30 ~ 2018-02-08
    OF - director → CIF 0
  • 5
    Cooper, Ashley Stephen Charles
    Chief Executive born in October 1960
    Individual (6 offsprings)
    Officer
    2015-09-18 ~ 2017-11-03
    OF - director → CIF 0
  • 6
    Dodd, Isabel
    Investment Associate born in July 1976
    Individual (1 offspring)
    Officer
    2019-03-21 ~ 2021-02-01
    OF - director → CIF 0
  • 7
    Hubbert, Simon
    Director born in July 1967
    Individual (3 offsprings)
    Officer
    2019-07-01 ~ 2020-02-10
    OF - director → CIF 0
  • 8
    Forward House, 17 High Street, Henley-in-arden, West Midlands, England
    Corporate (6 parents, 63 offsprings)
    Officer
    2016-04-04 ~ 2019-03-21
    PE - director → CIF 0
  • 9
    UNIVERSITY OF BRISTOL SERVICES LIMITED - now
    OVAL (745) LIMITED - 1991-12-10
    Red, Senate House, Tyndall Avenue, Bristol, England
    Dissolved corporate (2 parents)
    Person with significant control
    2016-04-06 ~ 2018-01-23
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

PERTINAX PHARMA LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
02023-01-01 ~ 2023-12-31
02022-01-01 ~ 2022-12-31
Par Value of Share
Class 2 ordinary share
02023-01-01 ~ 2023-12-31
Class 3 ordinary share
02023-01-01 ~ 2023-12-31
Class 4 ordinary share
02023-01-01 ~ 2023-12-31
Debtors
112 GBP2023-12-31
15,709 GBP2022-12-31
Cash at bank and in hand
58,424 GBP2023-12-31
69,813 GBP2022-12-31
Current Assets
58,536 GBP2023-12-31
85,522 GBP2022-12-31
Creditors
Current
1,100 GBP2023-12-31
7,933 GBP2022-12-31
Net Current Assets/Liabilities
57,436 GBP2023-12-31
77,589 GBP2022-12-31
Total Assets Less Current Liabilities
57,436 GBP2023-12-31
77,589 GBP2022-12-31
Other Debtors
Current, Amounts falling due within one year
112 GBP2023-12-31
15,709 GBP2022-12-31
Trade Creditors/Trade Payables
Current
600 GBP2023-12-31
7,333 GBP2022-12-31
Other Creditors
Current
500 GBP2023-12-31
600 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
100,000 shares2023-12-31
Class 3 ordinary share
163,556 shares2023-12-31
Class 4 ordinary share
34,127 shares2023-12-31
Equity
Share premium
2,195,757 GBP2023-12-31
2,195,757 GBP2022-12-31
Equity
77,556 GBP2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
-20,153 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-20,153 GBP2023-01-01 ~ 2023-12-31
Equity
Retained earnings (accumulated losses)
-2,138,354 GBP2023-12-31
  • PERTINAX PHARMA LIMITED
    Info
    Registered number 09557364
    Research & Enterprise Development University Of Bristol, 2nd Floor, Augustines Courtyard, Orchard Lane, Bristol BS1 5DS
    Private Limited Company incorporated on 2015-04-23 (10 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-04-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.